Advanced Search
Display options
Filter resources
Text Availability
Article type
Publication date
Species
Language
Sex
Age
Showing 1 to 12 of 134 entries
Sorted by: Best Match Show Resources per page
Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035.

Diabetes care

Rosenstock J, Aronson R, Grunberger G, Hanefeld M, Piatti P, Serusclat P, Cheng X, Zhou T, Niemoeller E, Souhami E, Davies M.
PMID: 28420696
Diabetes Care. 2017 Jun;40(6):809. doi: 10.2337/dc17-er06c. Epub 2017 Apr 18.

No abstract available.

Cite
Rosenstock J, Aronson R, Grunberger G, et al. Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035. Diabetes Care. 2017;40(6):809doi: 10.2337/dc17-er06c.
Rosenstock, J., Aronson, R., Grunberger, G., Hanefeld, M., Piatti, P., Serusclat, P., Cheng, X., Zhou, T., Niemoeller, E., Souhami, E., Davies, M. (2017). Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035. Diabetes care, 40(6), 809. https://doi.org/10.2337/dc17-er06c
Rosenstock, Julio, et al. "Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035." Diabetes care vol. 40,6 (2017): 809. doi: https://doi.org/10.2337/dc17-er06c
Rosenstock J, Aronson R, Grunberger G, Hanefeld M, Piatti P, Serusclat P, Cheng X, Zhou T, Niemoeller E, Souhami E, Davies M. Erratum. Benefits of LixiLan, a Titratable Fixed-Ratio Combination of Insulin Glargine Plus Lixisenatide, Versus Insulin Glargine and Lixisenatide Monocomponents in Type 2 Diabetes Inadequately Controlled on Oral Agents: The LixiLan-O Randomized Trial. Diabetes Care 2016;39:2026-2035. Diabetes Care. 2017 Jun;40(6):809. doi: 10.2337/dc17-er06c. Epub 2017 Apr 18. PMID: 28420696; PMCID: PMC5439410.
Copy Download .nbib Format: NLM
Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory".

Diabetes care

Cefalu WT, Rosenstock J, LeRoith D, Blonde L, Riddle MC.
PMID: 27208373
Diabetes Care. 2016 May;39(5):664-7. doi: 10.2337/dc16-0405.

No abstract available.

Cite
Cefalu WT, Rosenstock J, LeRoith D, et al. Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory". Diabetes Care. 2016;39(5):664-7doi: 10.2337/dc16-0405.
Cefalu, W. T., Rosenstock, J., LeRoith, D., Blonde, L., & Riddle, M. C. (2016). Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory". Diabetes care, 39(5), 664-7. https://doi.org/10.2337/dc16-0405
Cefalu, William T, et al. "Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory"." Diabetes care vol. 39,5 (2016): 664-7. doi: https://doi.org/10.2337/dc16-0405
Cefalu WT, Rosenstock J, LeRoith D, Blonde L, Riddle MC. Getting to the "Heart" of the Matter on Diabetic Cardiovascular Disease: "Thanks for the Memory". Diabetes Care. 2016 May;39(5):664-7. doi: 10.2337/dc16-0405. PMID: 27208373; PMCID: PMC5013718.
Copy Download .nbib Format: NLM
Neurofibromatosis type 1-associated hypertension secondary to coarctation of the thoracic aorta.

Clinical kidney journal

Mavani G, Kesar V, Devita MV, Rosenstock JL, Michelis MF, Schwimmer JA.
PMID: 25852916
Clin Kidney J. 2014 Aug;7(4):394-5. doi: 10.1093/ckj/sfu054. Epub 2014 Jun 05.

Neurofibromatosis type 1 (NF-1), also known as von Recklinghausen's disease, is an autosomal dominant genetic disorder. NF-I vasculopathy has been used to describe various vascular malformations associated with NF-1. Secondary hypertension related to NF-1 vasculopathy has been reported because...

Cite
Mavani G, Kesar V, Devita MV, et al. Neurofibromatosis type 1-associated hypertension secondary to coarctation of the thoracic aorta. Clin Kidney J. 2014;7(4):394-5doi: 10.1093/ckj/sfu054.
Mavani, G., Kesar, V., Devita, M. V., Rosenstock, J. L., Michelis, M. F., & Schwimmer, J. A. (2014). Neurofibromatosis type 1-associated hypertension secondary to coarctation of the thoracic aorta. Clinical kidney journal, 7(4), 394-5. https://doi.org/10.1093/ckj/sfu054
Mavani, Gaurang, et al. "Neurofibromatosis type 1-associated hypertension secondary to coarctation of the thoracic aorta." Clinical kidney journal vol. 7,4 (2014): 394-5. doi: https://doi.org/10.1093/ckj/sfu054
Mavani G, Kesar V, Devita MV, Rosenstock JL, Michelis MF, Schwimmer JA. Neurofibromatosis type 1-associated hypertension secondary to coarctation of the thoracic aorta. Clin Kidney J. 2014 Aug;7(4):394-5. doi: 10.1093/ckj/sfu054. Epub 2014 Jun 05. PMID: 25852916; PMCID: PMC4377800.
Copy Download .nbib Format: NLM
Application of sampling in the evaluation of health education materials.

Canadian journal of public health = Revue canadienne de sante publique

ROSENSTOCK IM.
PMID: 13260988
Can J Public Health. 1955 Sep;46(9):372-8.

No abstract available.

Cite
ROSENSTOCK IM. Application of sampling in the evaluation of health education materials. Can J Public Health. 1955;46(9):372-8
ROSENSTOCK, I. M. (1955). Application of sampling in the evaluation of health education materials. Canadian journal of public health = Revue canadienne de sante publique, 46(9), 372-8.
ROSENSTOCK, I M. "Application of sampling in the evaluation of health education materials." Canadian journal of public health = Revue canadienne de sante publique vol. 46,9 (1955): 372-8.
ROSENSTOCK IM. Application of sampling in the evaluation of health education materials. Can J Public Health. 1955 Sep;46(9):372-8. PMID: 13260988.
Copy Download .nbib Format: NLM
Cultural anthropology, social psychology, and sociology in public health.

American journal of public health and the nation's health

ROSENSTOCK IM.
PMID: 14494045
Am J Public Health Nations Health. 1961 Dec;51:1820-7. doi: 10.2105/ajph.51.12.1820.

No abstract available.

Cite
ROSENSTOCK IM. Cultural anthropology, social psychology, and sociology in public health. Am J Public Health Nations Health. 1961;51:1820-7doi: 10.2105/ajph.51.12.1820.
ROSENSTOCK, I. M. (1961). Cultural anthropology, social psychology, and sociology in public health. American journal of public health and the nation's health, 511820-7. https://doi.org/10.2105/ajph.51.12.1820
ROSENSTOCK, I M. "Cultural anthropology, social psychology, and sociology in public health." American journal of public health and the nation's health vol. 51 (1961): 1820-7. doi: https://doi.org/10.2105/ajph.51.12.1820
ROSENSTOCK IM. Cultural anthropology, social psychology, and sociology in public health. Am J Public Health Nations Health. 1961 Dec;51:1820-7. doi: 10.2105/ajph.51.12.1820. PMID: 14494045; PMCID: PMC1522879.
Copy Download .nbib Format: NLM
Public response to cancer screening and detection programs. Determinants of health behavior.

Journal of chronic diseases

ROSENSTOCK IM.
PMID: 13974968
J Chronic Dis. 1963 May;16:407-18. doi: 10.1016/0021-9681(63)90117-6.

No abstract available.

Cite
ROSENSTOCK IM. Public response to cancer screening and detection programs. Determinants of health behavior. J Chronic Dis. 1963;16:407-18doi: 10.1016/0021-9681(63)90117-6.
ROSENSTOCK, I. M. (1963). Public response to cancer screening and detection programs. Determinants of health behavior. Journal of chronic diseases, 16407-18. https://doi.org/10.1016/0021-9681(63)90117-6
ROSENSTOCK, I M. "Public response to cancer screening and detection programs. Determinants of health behavior." Journal of chronic diseases vol. 16 (1963): 407-18. doi: https://doi.org/10.1016/0021-9681(63)90117-6
ROSENSTOCK IM. Public response to cancer screening and detection programs. Determinants of health behavior. J Chronic Dis. 1963 May;16:407-18. doi: 10.1016/0021-9681(63)90117-6. PMID: 13974968.
Copy Download .nbib Format: NLM
Fallout Dosages at Washington, D.C.

Science (New York, N.Y.)

Blifford IH, Rosenstock HB.
PMID: 17740433
Science. 1956 Apr 13;123(3198):619-22. doi: 10.1126/science.123.3198.619.

It has been assumed that the fission product conglomerate emits one gamma ray per beta particle throughout its lifetime. The fallout velocities are not accurately known, and in some cases the detonation and response times have been approximated. For...

Cite
Blifford IH, Rosenstock HB. Fallout Dosages at Washington, D.C. Science. 1956;123(3198):619-22doi: 10.1126/science.123.3198.619.
Blifford, I. H., & Rosenstock, H. B. (1956). Fallout Dosages at Washington, D.C. Science (New York, N.Y.), 123(3198), 619-22. https://doi.org/10.1126/science.123.3198.619
Blifford, I H, and Rosenstock, H B. "Fallout Dosages at Washington, D.C." Science (New York, N.Y.) vol. 123,3198 (1956): 619-22. doi: https://doi.org/10.1126/science.123.3198.619
Blifford IH, Rosenstock HB. Fallout Dosages at Washington, D.C. Science. 1956 Apr 13;123(3198):619-22. doi: 10.1126/science.123.3198.619. PMID: 17740433.
Copy Download .nbib Format: NLM
Committee Reports: Committee on Evaluation and Standards: REPORT OF THE CHAIRMAN, 1967.

American journal of public health and the nation's health

Neter E, Olson TA, Press E, Reese EM, Roark KT, Rosenstock IM, Steele JH, Mattison BF, Baker AG, Bierman P, Byers DH, Huenemann RL, Kilcawley EJ, Langmuir AD, Moore FE, Hilbert MS.
PMID: 18018210
Am J Public Health Nations Health. 1968 Feb;58(2):365-6. doi: 10.2105/ajph.58.2.365.

No abstract available.

Cite
Neter E, Olson TA, Press E, et al. Committee Reports: Committee on Evaluation and Standards: REPORT OF THE CHAIRMAN, 1967. Am J Public Health Nations Health. 1968;58(2):365-6doi: 10.2105/ajph.58.2.365.
Neter, E., Olson, T. A., Press, E., Reese, E. M., Roark, K. T., Rosenstock, I. M., Steele, J. H., Mattison, B. F., Baker, A. G., Bierman, P., Byers, D. H., Huenemann, R. L., Kilcawley, E. J., Langmuir, A. D., Moore, F. E., & Hilbert, M. S. (1968). Committee Reports: Committee on Evaluation and Standards: REPORT OF THE CHAIRMAN, 1967. American journal of public health and the nation's health, 58(2), 365-6. https://doi.org/10.2105/ajph.58.2.365
Neter, E, et al. "Committee Reports: Committee on Evaluation and Standards: REPORT OF THE CHAIRMAN, 1967." American journal of public health and the nation's health vol. 58,2 (1968): 365-6. doi: https://doi.org/10.2105/ajph.58.2.365
Neter E, Olson TA, Press E, Reese EM, Roark KT, Rosenstock IM, Steele JH, Mattison BF, Baker AG, Bierman P, Byers DH, Huenemann RL, Kilcawley EJ, Langmuir AD, Moore FE, Hilbert MS. Committee Reports: Committee on Evaluation and Standards: REPORT OF THE CHAIRMAN, 1967. Am J Public Health Nations Health. 1968 Feb;58(2):365-6. doi: 10.2105/ajph.58.2.365. PMID: 18018210; PMCID: PMC1228167.
Copy Download .nbib Format: NLM
Light propagation through a moving gas.

Applied optics

Rosenstock HB, Hancock JH.
PMID: 20111109
Appl Opt. 1971 Jun 01;10(6):1299-307. doi: 10.1364/AO.10.001299.

A light beam sufficiently intense to appreciably heat a gas it traverses will be deflected on account of the heat-induced gradients in the index of refraction. We compute these effects (bending into the wind, and self-defocusing due to nonuniformities...

Cite
Rosenstock HB, Hancock JH. Light propagation through a moving gas. Appl Opt. 1971;10(6):1299-307doi: 10.1364/AO.10.001299.
Rosenstock, H. B., & Hancock, J. H. (1971). Light propagation through a moving gas. Applied optics, 10(6), 1299-307. https://doi.org/10.1364/AO.10.001299
Rosenstock, H B, and Hancock, J H. "Light propagation through a moving gas." Applied optics vol. 10,6 (1971): 1299-307. doi: https://doi.org/10.1364/AO.10.001299
Rosenstock HB, Hancock JH. Light propagation through a moving gas. Appl Opt. 1971 Jun 01;10(6):1299-307. doi: 10.1364/AO.10.001299. PMID: 20111109.
Copy Download .nbib Format: NLM
Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization.

Neurosurgery

Veznedaroglu E, Andrews DW, Benitez RP, Downes MB, Werner-Wasik M, Rosenstock J, Curran WJ, Rosenwasser RH.
PMID: 18596429
Neurosurgery. 2008 Feb;62:763-75. doi: 10.1227/01.neu.0000316280.99500.99.

OBJECTIVE: Despite the success of stereotactic radiosurgery, large inoperable arteriovenous malformations (AVMs) of 14 cm3 or more have remained largely refractory to stereotactic radiosurgery, with much lower obliteration rates. We review treatment of large AVMs either previously untreated or...

Cite
Veznedaroglu E, Andrews DW, Benitez RP, et al. Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization. Neurosurgery. 2008;62:763-75doi: 10.1227/01.neu.0000316280.99500.99.
Veznedaroglu, E., Andrews, D. W., Benitez, R. P., Downes, M. B., Werner-Wasik, M., Rosenstock, J., Curran, W. J., & Rosenwasser, R. H. (2008). Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization. Neurosurgery, 62763-75. https://doi.org/10.1227/01.neu.0000316280.99500.99
Veznedaroglu, Erol, et al. "Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization." Neurosurgery vol. 62 (2008): 763-75. doi: https://doi.org/10.1227/01.neu.0000316280.99500.99
Veznedaroglu E, Andrews DW, Benitez RP, Downes MB, Werner-Wasik M, Rosenstock J, Curran WJ, Rosenwasser RH. Fractionated stereotactic radiotherapy for the treatment of large arteriovenous malformations with or without previous partial embolization. Neurosurgery. 2008 Feb;62:763-75. doi: 10.1227/01.neu.0000316280.99500.99. PMID: 18596429.
Copy Download .nbib Format: NLM
Potential negative impacts and low effectiveness in the use of African annual killifish in the biocontrol of aquatic mosquito larvae in temporary water bodies.

Parasites & vectors

Reichard M, Watters BR, Wildekamp RH, Sonnenberg R, Nagy B, Polacik M, Valdesalici S, Cellerino A, Cooper BJ, Hengstler H, Rosenstock J, Sainthouse I.
PMID: 20846414
Parasit Vectors. 2010 Sep 16;3:89. doi: 10.1186/1756-3305-3-89.

Commentary and discussion on a recent paper promoting the use of Nothobranchius guentheri, a small African annual fish from the Island of Zanzibar as a tool to control mosquito larvae in temporary bodies of freshwater throughout Africa is presented.Arguments...

Cite
Reichard M, Watters BR, Wildekamp RH, et al. Potential negative impacts and low effectiveness in the use of African annual killifish in the biocontrol of aquatic mosquito larvae in temporary water bodies. Parasit Vectors. 2010;3:89doi: 10.1186/1756-3305-3-89.
Reichard, M., Watters, B. R., Wildekamp, R. H., Sonnenberg, R., Nagy, B., Polacik, M., Valdesalici, S., Cellerino, A., Cooper, B. J., Hengstler, H., Rosenstock, J., & Sainthouse, I. (2010). Potential negative impacts and low effectiveness in the use of African annual killifish in the biocontrol of aquatic mosquito larvae in temporary water bodies. Parasites & vectors, 389. https://doi.org/10.1186/1756-3305-3-89
Reichard, Martin, et al. "Potential negative impacts and low effectiveness in the use of African annual killifish in the biocontrol of aquatic mosquito larvae in temporary water bodies." Parasites & vectors vol. 3 (2010): 89. doi: https://doi.org/10.1186/1756-3305-3-89
Reichard M, Watters BR, Wildekamp RH, Sonnenberg R, Nagy B, Polacik M, Valdesalici S, Cellerino A, Cooper BJ, Hengstler H, Rosenstock J, Sainthouse I. Potential negative impacts and low effectiveness in the use of African annual killifish in the biocontrol of aquatic mosquito larvae in temporary water bodies. Parasit Vectors. 2010 Sep 16;3:89. doi: 10.1186/1756-3305-3-89. PMID: 20846414; PMCID: PMC2945331.
Copy Download .nbib Format: NLM
Report of the committee on evaluation and standards: report of the chairman, 1970.

American journal of public health

Steele JH, Arnold M, Aycock EK, Baker AG, Davenport FM, Donabedian A, Goldberg ID, Neter E, Olsen TA, Reese EM, Roark KT, Rosenstock IM, Silver GA, Steed HC.
PMID: 18008407
Am J Public Health. 1971 Feb;61(2):406-9. doi: 10.2105/ajph.61.2.406.

No abstract available.

Cite
Steele JH, Arnold M, Aycock EK, et al. Report of the committee on evaluation and standards: report of the chairman, 1970. Am J Public Health. 1971;61(2):406-9doi: 10.2105/ajph.61.2.406.
Steele, J. H., Arnold, M., Aycock, E. K., Baker, A. G., Davenport, F. M., Donabedian, A., Goldberg, I. D., Neter, E., Olsen, T. A., Reese, E. M., Roark, K. T., Rosenstock, I. M., Silver, G. A., & Steed, H. C. (1971). Report of the committee on evaluation and standards: report of the chairman, 1970. American journal of public health, 61(2), 406-9. https://doi.org/10.2105/ajph.61.2.406
Steele, J H, et al. "Report of the committee on evaluation and standards: report of the chairman, 1970." American journal of public health vol. 61,2 (1971): 406-9. doi: https://doi.org/10.2105/ajph.61.2.406
Steele JH, Arnold M, Aycock EK, Baker AG, Davenport FM, Donabedian A, Goldberg ID, Neter E, Olsen TA, Reese EM, Roark KT, Rosenstock IM, Silver GA, Steed HC. Report of the committee on evaluation and standards: report of the chairman, 1970. Am J Public Health. 1971 Feb;61(2):406-9. doi: 10.2105/ajph.61.2.406. PMID: 18008407; PMCID: PMC1530683.
Copy Download .nbib Format: NLM
Showing 1 to 12 of 134 entries